新冠疫情对慢性肾脏病恶化危机的影响：现在必须为早期检测提供资金。
Impact of COVID-19 on the worsening crisis of chronic kidney disease: the imperative to fund early detection is now.
机构信息
Kidney Health Australia, Melbourne, Victoria, Australia.
School of Medicine, Deakin University, Geelong, Victoria, Australia.
出版信息
Intern Med J. 2022 Apr;52(4):680-682. doi: 10.1111/imj.15670. Epub 2022 Mar 6.
Abstract
The number of Australians affected by kidney disease will increase as the impacts of COVID-19 infection on kidney health are realised. Chronic kidney disease (CKD) imposes significant health and economic burdens from dialysis costs, loss of employment, premature death and increased admissions to hospital. Screening for kidney disease must be integrated into post-COVID-19 care; however, currently there is no reimbursement for kidney health checks in primary care. Early detection can reduce the progression of CKD by as much as 50% and thus the imperative to fund the Kidney Health Check is now.
摘要
随着人们逐渐意识到 COVID-19 感染对肾脏健康的影响，受肾脏疾病影响的澳大利亚人数量将会增加。慢性肾脏疾病（CKD）给患者带来了巨大的健康和经济负担，包括透析费用、失业、早逝和住院率增加等。对肾脏疾病的筛查必须纳入 COVID-19 康复后的治疗中；然而，目前初级保健中并没有肾脏健康检查的报销。早期发现可以将 CKD 的进展减少多达 50%，因此现在有必要为肾脏健康检查提供资金。
相似文献
1
Impact of COVID-19 on the worsening crisis of chronic kidney disease: the imperative to fund early detection is now.新冠疫情对慢性肾脏病恶化危机的影响：现在必须为早期检测提供资金。
Intern Med J. 2022 Apr;52(4):680-682. doi: 10.1111/imj.15670. Epub 2022 Mar 6.
2
COVID-19 and chronic renal disease: clinical characteristics and prognosis.COVID-19 与慢性肾脏病：临床特征与预后。
QJM. 2020 Nov 1;113(11):799-805. doi: 10.1093/qjmed/hcaa258.
3
Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.土耳其全国性分析：与无肾病患者相比，慢性肾脏病、血液透析和肾移植患者 COVID-19 感染的死亡率分析。
Nephrol Dial Transplant. 2020 Dec 4;35(12):2083-2095. doi: 10.1093/ndt/gfaa271.
4
Taming the chronic kidney disease epidemic: a global view of surveillance efforts.遏制慢性肾脏病流行：全球监测工作概览
Kidney Int. 2014 Aug;86(2):246-50. doi: 10.1038/ki.2014.190. Epub 2014 Jun 4.
5
Review article: Early detection of chronic kidney disease in Australia: which way to go?综述文章：澳大利亚慢性肾脏病的早期检测：路在何方？
Nephrology (Carlton). 2009 Jun;14(4):367-73. doi: 10.1111/j.1440-1797.2009.01113.x.
6
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用：对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
7
Screening and early detection of chronic kidney disease at primary healthcare.在基层医疗保健中进行慢性肾脏病的筛查和早期检测。
Clin Exp Hypertens. 2021 Jul 4;43(5):416-418. doi: 10.1080/10641963.2021.1896726. Epub 2021 Mar 17.
8
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?慢性肾脏病分期和心血管疾病对中重度肾脏病患者年度住院费用有何影响？
BMC Nephrol. 2015 Apr 29;16:65. doi: 10.1186/s12882-015-0054-0.
9
Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence.澳大利亚、新西兰和加拿大针对原住民的慢性肾病管理项目的效果、成本效益、可接受性和实施障碍/促进因素：混合证据的系统评价。
BMC Health Serv Res. 2016 Apr 6;16:119. doi: 10.1186/s12913-016-1363-0.
10
eMAP:CKD: electronic diagnosis and management assistance to primary care in chronic kidney disease.eMAP：CKD：慢性肾脏病初级保健中的电子诊断和管理辅助。
Nephrol Dial Transplant. 2018 Jan 1;33(1):121-128. doi: 10.1093/ndt/gfw366.
引用本文的文献
1
Shared decision making in chronic kidney disease: a qualitative study of the impact of communication practices on treatment decisions for older patients.慢性肾脏病中的共同决策：沟通实践对老年患者治疗决策影响的定性研究。
BMC Nephrol. 2023 Dec 21;24(1):383. doi: 10.1186/s12882-023-03406-9.
本文引用的文献
1
eGFR Decline after SGLT2 Inhibitor Initiation: The Tortoise and the Hare Reimagined.SGLT2抑制剂起始治疗后的估算肾小球滤过率下降：重新构想的龟兔赛跑
Kidney360. 2021 Mar 26;2(6):1042-1047. doi: 10.34067/KID.0001172021. eCollection 2021 Jun 24.
2
Metabolic disorders, COVID-19 and vaccine-breakthrough infections.代谢紊乱、COVID-19 和疫苗突破性感染。
Nat Rev Endocrinol. 2022 Feb;18(2):75-76. doi: 10.1038/s41574-021-00608-9.
3
Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.COVID-19 后 273618 例幸存者的 6 个月回顾性队列研究：长新冠症状的发生率、共病和演变。
PLoS Med. 2021 Sep 28;18(9):e1003773. doi: 10.1371/journal.pmed.1003773. eCollection 2021 Sep.
4
Hospitalisation among vaccine breakthrough COVID-19 infections.疫苗突破性新冠病毒感染导致的住院情况。
Lancet Infect Dis. 2021 Nov;21(11):1485-1486. doi: 10.1016/S1473-3099(21)00558-2. Epub 2021 Sep 7.
5
Kidney Outcomes in Long COVID.长新冠对肾脏的影响。
J Am Soc Nephrol. 2021 Nov;32(11):2851-2862. doi: 10.1681/ASN.2021060734. Epub 2021 Sep 1.
6
Incidence and Outcomes of Acute Kidney Injury in COVID-19: A Systematic Review.新型冠状病毒肺炎相关急性肾损伤的发生率和结局：系统评价。
Blood Purif. 2022;51(3):199-212. doi: 10.1159/000514940. Epub 2021 Jun 15.
7
Renal Injury by SARS-CoV-2 Infection: A Systematic Review.新型冠状病毒2型感染所致肾损伤：一项系统评价
Kidney Dis (Basel). 2021 Mar;7(2):100-110. doi: 10.1159/000512683. Epub 2020 Nov 16.
8
Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19.评估 COVID-19 患者与非 COVID-19 患者出院后的急性肾损伤和纵向肾功能。
JAMA Netw Open. 2021 Mar 1;4(3):e211095. doi: 10.1001/jamanetworkopen.2021.1095.
9
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury.COVID-19 合并急性肾损伤患者的住院结局。
Am J Kidney Dis. 2021 Feb;77(2):204-215.e1. doi: 10.1053/j.ajkd.2020.09.002. Epub 2020 Sep 19.
10
COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.COVID-19 相关肾损伤：肾活检结果的病例系列。
J Am Soc Nephrol. 2020 Sep;31(9):1948-1958. doi: 10.1681/ASN.2020050699. Epub 2020 Jul 13.
Zotero 插件